Botox battle lands in Texas court

Botox battle lands in Texas court

A French biopharma group has asked a US court to enforce an ICC award that restrains its Swiss partner Galderma from independently obtaining regulatory approval for a novel Botox treatment.

Unlock unlimited access to all Global Arbitration Review content